Lixte names Denham Capital founder Stuart Porter to board amid strategic shift

Lixte Biotechnology

Lixte Biotechnology

LIXT

0.00
  • Lixte Biotechnology named Denham Capital founder Stuart D. Porter to its board, effective today.
  • Porter is Denham’s founder, managing partner, CEO, chief investment officer; oversaw more than $12 billion across energy, energy-transition investments.
  • Board addition aligns with Lixte’s shift toward AI power infrastructure equipment and services for data centers.
  • Denham’s infrastructure group is advancing about 10 GW of AI data-center-oriented power generation opportunities in the US and Europe.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lixte Biotechnology Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606010850PRIMZONEFULLFEED9729655) on June 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.